Hello,
According to CLSI EP09-A3 various regression techniques are available to assess the linear relationship between 2 analytical methods. Deming (D) is implemented within JMP as Orthogonal Fit. What is missing are 2 methods which are more appropriate for most (if not all) chemical or immunological assays (oncology, virology, cardiovascular, inflammatory medical devices) i.e. weighted-Deming (wD) which take care of the heteroscedasticity of the measurement (that's always the case for immuno-assays) and Passing-Bablok (PB) which in addition is robust to outliers (that's often the case). The later (PB) being the best in class and most commonly used in the field.
For that reason Analyze-it (EXCEL add-in) is still used for regulatory submission (FDA, cFDA, CE marking) rather than JMP for linear regression assesment.
Emmanuel (former Beckman-Coulter employee)